Yusuke Suzuki

Active 1978–2026

342
Papers
21,092
Citations
76
h-index
218
i10-index

Citations

Citations per year for Yusuke Suzuki1979: 1 citations1991: 1 citations1992: 1 citations1994: 2 citations1995: 3 citations1996: 2 citations1997: 1 citations1998: 2 citations1999: 1 citations2000: 4 citations2001: 12 citations2002: 41 citations2003: 50 citations2004: 64 citations2005: 83 citations2006: 76 citations2007: 82 citations2008: 87 citations2009: 96 citations2010: 90 citations2011: 104 citations2012: 105 citations2013: 95 citations2014: 152 citations2015: 143 citations2016: 120 citations2017: 162 citations2018: 189 citations2019: 490 citations2020: 594 citations2021: 685 citations2022: 650 citations2023: 700 citations2024: 1,260 citations2025: 573 citations2026: 27 citations1980–1990: no citations, so these years are not shown1993: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,573 citing papers, 17.8% of this breakdownChina: 1,200 citing papers, 13.6% of this breakdownJapan: 868 citing papers, 9.8% of this breakdownUnited Kingdom: 545 citing papers, 6.2% of this breakdownGermany: 426 citing papers, 4.8% of this breakdownItaly: 364 citing papers, 4.1% of this breakdownCanada: 314 citing papers, 3.6% of this breakdownAustralia: 297 citing papers, 3.4% of this breakdownFrance: 265 citing papers, 3% of this breakdownSpain: 249 citing papers, 2.8% of this breakdownNetherlands: 199 citing papers, 2.3% of this breakdownSouth Korea: 154 citing papers, 1.7% of this breakdown
0%17.8%Other 26.9%

Fields

  • Medicine57.7%
  • Biochemistry, Genetics and Molecular Biology13.1%
  • Computer Science9.6%
  • Immunology and Microbiology7.4%
  • Neuroscience4.5%
  • Engineering1.7%
  • Other6%

Topics

  • Renal Diseases and Glomerulopathies6.9%
  • Chronic Kidney Disease and Diabetes4.5%
  • Asthma and respiratory diseases2.1%
  • Vasculitis and related conditions2%
  • Dialysis and Renal Disease Management1.7%
  • IL-33, ST2, and ILC Pathways1.6%
  • Other81.2%

Coauthors

All papers

Open in search
  1. KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Kidney International 2021 cited by 2,416

  2. Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Martin Howell, Marcello Tonelli, Michael Cheung, Amy Earley, Jürgen Floege - Kidney International 2021 cited by 791

  3. Oxford Classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Maria Fernanda Soares, Yusuke Suzuki, Katsuo Takahashi, Stéphan Troyanov, Jacobien C. Verhave, Suxia Wang, Jan J. Weening, Robert Wyatt, Nori Yoshikawa, Caihong Zeng - Kidney International 2017 cited by 1,171

  4. An update on the global disparities in kidney disease burden and care across world countries and regions

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Smita Divyaveer, Udeme E. Ekrikpo, Isabelle Ethier, Winston Wing-Shing Fung, Abduzhappar Gaipov, Anukul Ghimire, Ghenette Houston, Kwaifa Salihu Ibrahim, Georgina Irish, Kailash Jindal, Dearbhla M. Kelly, Liz Lightstone, Magdalena Madero, Aisha M. Nalado, Brendon L. Neuen, Timothy O. Olanrewaju, Mohamed A. Osman, Rulan S. Parekh, Anna Petrova, Narayan Prasad, Larisa Prikhodina, Sanjin Racki, Parnian Riaz, Syed Saad, Aminu Muhammad Sakajiki, Shokoufeh Savaj, Dibya Singh Shah, Yusuke Suzuki, Vladimir Tesar, Sophanny Tiv, Somkanya Tungsanga, Carmen Tzanno-Martins, Andrea Viecelli, Angela Yee-Moon Wang, Muh Geot Wong, Deenaz Zaidi - The Lancet Global Health 2024 cited by 449

  5. Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Gloria Ashuntantang, Shakti Basnet, Aminu K. Bello, Worawon Chailimpamontree, Ricardo Correa‐Rotter, Jonathan C. Craig, Walter Douthat, Harold I. Feldman, Mohammad Reza Ganji, Guillermo García-García, Mohammed Benghanem Gharbi, David C.H. Harris, Vivekanand Jha, David W. Johnson, Rümeyza Kazancıoğlu, Robyn G. Langham, Zhi-Hong Liu, Ziad A. Massy, Masaomi Nangaku, Robert G. Nelson, Dónal O’Donoghue, Ikechi G. Okpechi, Roberto Pecoits‐Filho, Neil R. Powe, Giuseppe Remuzzi, Charlotte Roberts, Jérôme Rossert, Laura Solá, Bénédicte Stengel, Ernest K. Sumaili M, Yusuke Suzuki, Tetsuhiro Tanaka, Sajja Tatiyanupanwong, Bernadette Thomas, Katrin Uhlig, Robert G. Walker, S. L. White, Andrzej Więcek, Chih-Wei Yang - The Lancet 2017 cited by 923

  6. A Phase 2 Trial of Sibeprenlimab in Patients with IgA Nephropathy

    Authors: , , , , , , , , , , , - New England Journal of Medicine 2023 cited by 196

  7. Evaluating a New International Risk-Prediction Tool in IgA Nephropathy

    Authors: , , , , , , , , , , , , , - JAMA Internal Medicine 2019 cited by 475

  8. Efficacy and safety of garadacimab, a factor XIIa inhibitor for hereditary angioedema prevention (VANGUARD): a global, multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet 2023 cited by 113

  9. Randomized Phase II JANUS Study of Atacicept in Patients With IgA Nephropathy and Persistent Proteinuria

    Authors: , , , , , , , , - Kidney International Reports 2022 cited by 92

  10. Thymic stromal lymphopoietin induces corticosteroid resistance in natural helper cells during airway inflammation

    Authors: , , , , , , , , - Nature Communications 2013 cited by 339

  11. Moderators of the effect of therapeutic exercise for knee and hip osteoarthritis: a systematic review and individual participant data meta-analysis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Rana S. Hinman, M. Hopman-Rock, Michael Hurley, Justin Keogh, Cindy Veenhof, J. Knoop, Inga Krauß, Pazit Levinger, Christopher J. McCarthy, Stephen P. Messier, Ari Heinonen, Håvard Østerås, Shahnawaz Anwer, Ana Cristina Rodrigues Lacerda, G. Shankar Ganesh, Benjamin Steinhilber, Yusuke Suzuki, Michael A. Hunt, Laura A. Talbot, C.H. Teirlinck, Michael Doherty, Pao‐Feng Tsai, Jason A. Wallis, Merve Yılmaz Menek - The Lancet Rheumatology 2023 cited by 123

  12. TLR9 activation induces aberrant IgA glycosylation via APRIL- and IL-6–mediated pathways in IgA nephropathy

    Authors: , , , , , , - Kidney International 2019 cited by 161

  13. Inflammation and angiotensin II

    Authors: , , , , , - The International Journal of Biochemistry & Cell Biology 2003 cited by 692

  14. Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneity

    Authors: , , , , , , , , , , , , , , , - Journal of Clinical Investigation 2009 cited by 453

  15. Toll-Like Receptor 9 Stimulation Induces Aberrant Expression of a Proliferation-Inducing Ligand by Tonsillar Germinal Center B Cells in IgA Nephropathy

    Authors: , , , , , , , , , , , - Journal of the American Society of Nephrology 2016 cited by 143

  16. Identification of IgA autoantibodies targeting mesangial cells redefines the pathogenesis of IgA nephropathy

    Authors: , , , , , , , , , , , , - Science Advances 2023 cited by 64

  17. Lipopolysaccharide-Deficient Acinetobacter baumannii Due to Colistin Resistance Is Killed by Neutrophil-Produced Lysozyme

    Authors: , , , , , , , , , , , , , , , - Frontiers in Microbiology 2020 cited by 53

  18. Apoptosis inhibitor of macrophage protein enhances intraluminal debris clearance and ameliorates acute kidney injury in mice

    Authors: , , , , , , , , , , , , , , , , , , , , - Nature Medicine 2016 cited by 225

  19. A Proliferation Inducing Ligand (APRIL) targeted antibody is a safe and effective treatment of murine IgA nephropathy

    Authors: , , , , , , , , , , , , - Kidney International 2019 cited by 90

  20. Randomized, double-blind, placebo-controlled phase 3 study of bardoxolone methyl in patients with diabetic kidney disease: design and baseline characteristics of the AYAME study

    Authors: , , , , , , , , , , , , , - Nephrology Dialysis Transplantation 2022 cited by 44

  21. Application of the International IgA Nephropathy Prediction Tool one or two years post-biopsy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Antonello Pani, Doloretta Piras, Andrea Angioi, Giovanni Cancarini, S. Ravera, Magdalena Durlik, Elisabetta Moggia, José Ballarín, S. Di Giulio, Francesco Pugliese, I. Serriello, Y. Caliskan, Mehmet Şükrü Sever, İşın Kiliçaslan, Francesco Locatelli, Lucia Del Vecchio, Jack F.M. Wetzels, Harm Peters, U. Berg, Fernanda Carvalho, A.C. da Costa Ferreira, M. Maggio, Andrzej Więcek, Mai Ots-Rosenberg, Riccardo Magistroni, Rezan Topaloğlu, Yelda Bilginer, Marco DʼAmico, Μaria Stangou, F Giacchino, Dimitrios Goumenos, Evangelos Papachristou, Kres̆imir Gales̃ić, Colin Geddes, Kostas C. Siamopoulos, Olga Balafa, Marco Galliani, Piero Stratta, Marco Quaglia, R Bergia, Raffaella Cravero, Maurizio Salvadori, Lino Cirami, Bengt Fellström, Hilde Kloster Smerud, Franco Ferrario, T. Stellato, Jesús Egido, Carina Aguilar Martín, Jürgen Floege, Frank Eitner, Antonio Lupo, Patrizia Bernich, Paolo Mené, Massimo Morosetti, Cees van Kooten, Ton J. Rabelink, Marlies E. J. Reinders, J.M. Boria Grinyo, Stefano Cusinato, Luisa Benozzi, Silvana Savoldi, C. Licata, Małgorzata Mizerska-Wasiak, G Martina, A Messuerotti, Antonio Dal Canton, Ciro Esposito, C. Migotto, G Triolo and 102 more - Kidney International 2022 cited by 76

  22. IgA nephropathy and IgA vasculitis with nephritis have a shared feature involving galactose-deficient IgA1-oriented pathogenesis

    Authors: , , , , , , , - Kidney International 2018 cited by 227

  23. Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of VIS649 (Sibeprenlimab), an APRIL-Neutralizing IgG2 Monoclonal Antibody, in Healthy Volunteers

    Authors: , , , , , , , - Kidney International Reports 2022 cited by 44

  24. Sparsentan is superior to losartan in the gddY mouse model of IgA nephropathy

    Authors: , , , , , , , , , , , , - Nephrology Dialysis Transplantation 2024 cited by 33